Evidence map›Paper›PMID 35895679›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy.

Sho Ueda, Satoshi Yamashita, Miho Nakajima, Tadashi Kumamoto, Chitose Ogawa, Yu-Yu Liu, Harumi Yamada, Emi Kubo, Naoko Hattori, Hideyuki Takeshima and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Platinum accumulation in chemotherapy: toxicity mechanisms, challenges, and mitigation strategies.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Effect of sequencing platforms on the sensitivity of chemical mutation detection using Hawk-Seq™.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  9. Article
  10. Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Sho UedaDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0001-6899-2198
Satoshi YamashitaDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.
Miho NakajimaDepartment of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan, 104-0045.ORCID 0000-0003-4922-6257
Tadashi KumamotoDepartment of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan, 104-0045.
Chitose OgawaDepartment of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan, 104-0045.
Yu-Yu LiuDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0002-4814-8616
Harumi YamadaDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0002-6619-9310
Emi KuboDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0001-9369-2824
Naoko HattoriDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0002-0901-4869
Hideyuki TakeshimaDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0002-8552-2427
Mika WakabayashiDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.
Naoko IidaDivision of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0002-9790-2865
Yuichi ShiraishiDivision of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0001-6144-5845
Masayuki NoguchiDepartment of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 305-8576.
Yukio SatoDepartment of Thoracic Surgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 305-8576.ORCID 0000-0002-4947-6240
Toshikazu UshijimaDivision of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan, 104-0045.ORCID 0000-0003-3405-7817
University of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic mutations are accumulated in normal human tissues with aging and exposure to carcinogens. If we can accurately count any passenger mutations in any single DNA molecule, since their quantity is much larger than driver mutations, we can sensitively detect mutation accumulation in polyclonal normal tissues. Duplex sequencing, which tags both DNA strands in one DNA molecule, enables accurate count of such mutations, but requires a very large number of sequencing reads for each single sample of human-genome size. Here, we reduced the genome size to 1/90 using the

Indexed as

DNA Mutational AnalysisGenome, HumanHigh-Throughput Nucleotide SequencingMutation RateSingle Molecule ImagingAgingBase PairingChildHumansMutationchemotherapyduplex sequencingnext-generation sequencingnormal tissuesomatic mutation

Identifiers

PMID35895679
PMCPMC9351471
OpenAlexW4288067353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.